Navigation Links
Emdeon Reports Third Quarter 2011 Results
Date:11/9/2011

,207

-

20,207Inter-segment revenue 852

151

-

(1,003)

-758

83

-

(841)

-Net revenue 115,775

145,723

21,654

(1,003)

282,149108,054

118,503

20,207

(841)

245,923Costs and expenses:Cost of operations 77,979

88,958

8,909

(939)

174,90770,876

73,040

7,811

(809)

150,918Development and engineering 3,077

4,705

1,748

-

9,5302,812

4,004

1,780

-

8,596Sales, marketing, general and administrative 6,986

7,810

1,537

18,500

34,8336,576

7,626

1,459

12,833

28,494Segment contribution (1)$
27,733

$
44,250

$
9,460

$
(18,564)

62,879$
27,790

$
33,833

$
9,157

$
(12,865)

57,915Depreciation and amortization 39,83030,001Interest income (4)(4)Interest expense 12,57716,163Other(4,398)(2,370)Income before income tax provision $
4,874$
4,125For the Nine Months Ended September 30, 2011For the Nine Months Ended September 30, 2010Corporate &Corporate &PayerProviderPharmacyEliminationsConsolidatedPayerProviderPharmacyEliminationsConsolidatedRevenue from external customers Claims management$
53,679

$
-

$
-

$
-

$
53,679$
43,770

$
-

$
-

$
-

$
43,770Payment services186,512

-

-

-

186,512171,693

-

-

-

171,693Patient statements-

192,813

-

-

192,813-

198,214

-

-

198,214Revenue cycle management-

216,238

-

-

216,238
'/>"/>

SOURCE Emdeon Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Emdeon to Present at the Piper Jaffray Annual Health Care Conference
2. Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality
3. Emdeon Recommends Secure Interim Solutions to Avert Delays in the Implementation of ePrescribing of Controlled Substances
4. Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity
5. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... July 7, 2015 BioRx, a Diplomat company (NYSE: ... a Top Workplace in 2015 based on a survey held ... Media Group and a Philadelphia -based research ... and was completed by employees across the Greater ... area, with topics ranging from workplace environment to overall organizational ...
(Date:7/7/2015)... 7, 2015 Hill-Rom,s recent announcement that ... in cash and stock means the company can ... to Kalorama Information. The healthcare market researcher said ... device and advanced wound care markets, and is ... lifting devices, and other healthcare equipment. Welch Allyn,s ...
(Date:7/7/2015)... --  ICD-10 Charts ( www.icd10charts.com ) announced today ... officially launched its newest line of ICD-10 preparation ... new 4 Step ICD-10 Implementation Plan.  Both of ... Charts resources and mobile apps, are available to ... the release of these resources, the company has ...
Breaking Medicine Technology:BioRx Named a Top Workplace in 2015 by Enquirer Media 2BioRx Named a Top Workplace in 2015 by Enquirer Media 3Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 2Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4
... WIRE)--May 15, 2007 - Synthetic Blood,International, Inc. ... analysis of its Phase IIa study with ... line with preliminary,study results announced in December ... of increasing patients' oxygen,tension levels compared with ...
... WIRE)--May 17, 2007 - Salix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) today ... the Company's products,will be presented at Digestive Disease ... Digestive Disease Week is considered the,largest and most ... Every year it attracts more than 16,000 physicians,researchers ...
Cached Medicine Technology:Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5
(Date:7/7/2015)... ... ... Enterprises, LLC has announced the opening of its newest store location in Zanesville, Ohio. The ... The premium frozen yogurt chain was listed as #22 on the Inc. 500 list of ... Zanesville, OH 43701. , “We are thrilled to finally open a store in Zanesville ...
(Date:7/7/2015)... ... ... a reputable source of authentic tickets for the CONCACAF Gold Cup Group A ... Foxborough, Massachusetts. , The second round of matches being held from Group A of the ... will be held on Friday, July 10th and will feature Honduras vs. Panama and the ...
(Date:7/7/2015)... ... July 07, 2015 , ... An article published June ... how innovation and technology would be the “key factors” in the growth of ... accessibility and affordability, especially in emerging and growing markets. According to the compounding ...
(Date:7/7/2015)... ... 07, 2015 , ... Researchers at UC Davis have reviewed ... didn’t) and how similar programs can be improved. , Interviewing staff, clinicians and ... of Practice (HEALTH COP) program, the team identified four factors that helped clinicians ...
(Date:7/7/2015)... Washington (PRWEB) , ... July 07, 2015 , ... ... that will provide payment parity for an expanded list of telehealth services available ... bi-partisan sponsorship from Representatives Gregg Harper (R-MS 3), Diane Black (R-TN 6) and ...
Breaking Medicine News(10 mins):Health News:sweetFrog Grows in Ohio with New Store Opening 2Health News:CONCACAF Group A Tickets: USA vs. Haiti & Honduras vs. Panama at Gillette Stadium: Ticket Down Slashes CONCACAF Gold Cup Group A Tickets in Foxborough 2Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 2Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 3Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 2Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 3Health News:The American Telemedicine Association Supports Legislation to Expand Medicare Coverage for Telemedicine Services 2
... health research? The National Institutes of Health (NIH) wants ... meeting March 4-6 on behalf of the NIH Office ... develop research priorities for the next decade. The meeting ... scientists, health-care providers, patients, community groups, advocacy groups and ...
... the University of California, San Diego, Stanford University School of ... a chronic form of leukemia can progress into a deadlier ... an indicator of when this type of cancer chronic ... more accurate prognoses for the disease and improved treatment choices. ...
... BMP Sunstone,Corporation (Nasdaq: BJGP ) (,BMP ... 8, 2009, senior executives of Sunstone (Tangshan),Pharmaceutical Co., ... Vice Premier of,the State Counsel of the PRC, ... and other senior central and local government officials. ...
... Medical Interpreters Association (IMIA) appointed a representative for ... The IMIA is proud to announce Lola Bendana, ... for Canada. Her role is primarily to represent ... and initiate activities that will promote the medical ...
... Nektar Therapeutics (Nasdaq: NKTR ) announced today ... Phase 1 dose-escalation study of NKTR-105, a novel PEGylated ... assess the safety, pharmacokinetics and anti-tumor activity of NKTR-105 ... have failed all prior available therapies. "The start ...
... GlaxoSmithKline today announced initiation and dosing of the ... programme to evaluate the efficacy, safety and tolerability ... Syncria(R) (albiglutide) in men and women with type ... include more than 4,000 patients."Despite continued advances in ...
Cached Medicine News:Health News:WU hosts public hearing, conference to help NIH prioritize women's health research 2Health News:Scientists uncover indicator that warns leukemia is progressing to more dangerous form 2Health News:Scientists uncover indicator that warns leukemia is progressing to more dangerous form 3Health News:BMP Sunstone Reiterates Commitment to Quality, Innovation and Long-Term Growth at Meeting with Senior Officials 2Health News:BMP Sunstone Reiterates Commitment to Quality, Innovation and Long-Term Growth at Meeting with Senior Officials 3Health News:IMIA Interpreter Association Appoints Canada Representative 2Health News:IMIA Interpreter Association Appoints Canada Representative 3Health News:Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors 2Health News:Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors 3Health News:Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors 4Health News:GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide) 2Health News:GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide) 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: